Intas Pharmaceuticals Ltd

Morgan Stanley India Company Pvt Ltd

Public issue of upto [*] equity shares of face value of Rs. 10 each (Equity Shares) of Intas Pharmaceuticals Limited (The company or The Issuer) for cash at a price of Rs. [*] per equity share including a share premium of Rs. [*] per equity share, aggregating up to Rs. [*] crores (The Issue) comprising of a fresh issue of upto equity shares by the company aggregating upto Rs. 225.00 crores (The Fresh Issue) and an offer for sale of 11,621,100 equity shares by Mozart Limited aggregating upto Rs. [*] crores (The Selling Shareholder) (The Offer for sale). The issue shall constitute [*]% of the post-issue paid up capital and [*]% of the fully diluted post-issue paid up capital of the company. The Face value of the equity share is Rs. 10 each.

  • Issue

    • Opens OnInvalid date
    • Closes OnInvalid date
  • Money Payable On

    • Application0
    • Allotment0
  • Project Cost (Cr.)0
  • Post Issue Equity Share Capital (Cr.)0
  • Issue Price (D)0

Further Multiples of: 0

Projects

  • Promoted By
    • Listing AtNSE
    • Registrar to the Issue - Link Intime India Pvt Ltd

    2nd Floor Chinubhai Centre Ashram Road Ahmedabad

    Gujarat- 380009

    Phone - 91-079-26576655

    Fax - 91-079-26578862

    Email - manoj_nair@intaspharma.com

    Website - www.intaspharma.com

    Ready to invest with us?

    Share your Mobile Number with us and get started

    • +91|
    scrollToTop